CVJun 6, 2024

LNQ Challenge 2023: Learning Mediastinal Lymph Node Segmentation with a Probabilistic Lymph Node Atlas

arXiv:2406.03984v13 citationsHas Code
Originality Incremental advance
AI Analysis

This work addresses the resource-intensive problem of lymph node detection for cancer staging, but it is incremental as it builds on existing methods with specific modifications for a challenge dataset.

The paper tackled mediastinal lymph node segmentation by incorporating a probabilistic lymph node atlas and handling partial annotations, achieving a Dice score of 0.6033 and segmenting 57% of ground truth lymph nodes compared to 27% with CT-only training.

The evaluation of lymph node metastases plays a crucial role in achieving precise cancer staging, influencing subsequent decisions regarding treatment options. Lymph node detection poses challenges due to the presence of unclear boundaries and the diverse range of sizes and morphological characteristics, making it a resource-intensive process. As part of the LNQ 2023 MICCAI challenge, we propose the use of anatomical priors as a tool to address the challenges that persist in mediastinal lymph node segmentation in combination with the partial annotation of the challenge training data. The model ensemble using all suggested modifications yields a Dice score of 0.6033 and segments 57% of the ground truth lymph nodes, compared to 27% when training on CT only. Segmentation accuracy is improved significantly by incorporating a probabilistic lymph node atlas in loss weighting and post-processing. The largest performance gains are achieved by oversampling fully annotated data to account for the partial annotation of the challenge training data, as well as adding additional data augmentation to address the high heterogeneity of the CT images and lymph node appearance. Our code is available at https://github.com/MICAI-IMI-UzL/LNQ2023.

Code Implementations1 repo
Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes